# Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

> **NCT07510607** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ari Green** · enrollment: 40 (estimated)

## Conditions studied

- Multiple Sclerosis
- RRMS
- Relapsing Remitting MS

## Interventions

- **DRUG:** HP 13C pyruvate injection
- **DEVICE:** MRI Scanner

## Key facts

- **NCT ID:** NCT07510607
- **Lead sponsor:** Ari Green
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07510607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07510607, "Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07510607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*